CHI3L1 and Huntington disease: Neuroinflammation remains a promising area in the field of biomarker research with additional complement components shown to be upregulated in the plasma of HD patients [99] and CSF YKL-40, a microglial marker, showing disease related elevations and the ability to independently predict clinical severity and neuronal death [100].